參考文獻/References:
[1] 中華醫(yī)學(xué)會骨質(zhì)疏松和骨礦鹽疾病分會.原發(fā)性骨質(zhì)疏松癥診療指南(2017)[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2017,20(5):413-444.
[2] 謝冠豪.補腎活血中藥預(yù)防骨質(zhì)疏松性椎體骨折的有限元研究[D].廣州:廣州中醫(yī)藥大學(xué),2014.
[3] 中華醫(yī)學(xué)會骨科學(xué)分會骨質(zhì)疏松學(xué)組.骨質(zhì)疏松性骨折診療指南[J].中華骨科雜志,2017,37(1):1-10.
[4] 金明柱,鄭洪新.骨痿與骨質(zhì)疏松癥[J].遼寧中醫(yī)雜志,2007,34(3):286-287.
[5] 于思明,楊延博.古今醫(yī)家辨治“骨痿”異同淺述[J].浙江中醫(yī)藥大學(xué)學(xué)報,2018,42(2):168-17
[6] 鄧昶,周明旺,付志斌,等.骨質(zhì)疏松癥的中醫(yī)病因病機及其治療進展[J].中國骨質(zhì)疏松雜志,2017,23(8):1105-1111.
[7] 郁志華,林水淼.論“五臟之精”及其在中醫(yī)防治老年病中的意義[J].中國中醫(yī)藥現(xiàn)代遠(yuǎn)程教育,2015,13(6):8-10.
[8] 史曉林,梁博程,李春雯.從“因虛致瘀”論原發(fā)性骨質(zhì)疏松癥病機[J].中國中西醫(yī)結(jié)合雜志,2019,39(1):111-114.
[9] 羅秀夏.淺析虛瘀并存的瘀血證[J].北京中醫(yī)藥大學(xué)學(xué)報(中醫(yī)臨床版),2006,13(3):43-44.
[10] 姚杰良,黎忠民,吳素蓉.治虛勿忘治瘀淺說[J].四川中醫(yī),2009,27(8):36-37.
[11] 曹奇圣,劉翔,王力.從腎虛瘀血論探討原發(fā)性骨質(zhì)疏松癥疼痛的發(fā)病機理[J].江西中醫(yī)藥,2018,49(4):78-80.
[12] 卞胡偉,蔣濤.孟河醫(yī)派“脾腎相關(guān)、活血化瘀”治療骨質(zhì)疏松初探[J].江西中醫(yī)藥,2016,47(6):10-12.
[13] 史曉林,王健,王博,等.虛瘀兼顧——治療原發(fā)性骨質(zhì)疏松癥的基本原則[J].中醫(yī)正骨,2017,29(3):14-16.
[14] 朱愛松,鄭洪新.論中醫(yī)病因之“毒”[J].醫(yī)學(xué)信息,2009,22(6):997-998.
[15] 施振宇,劉鐘,陳文亮,等.中醫(yī)綜合療法防治絕經(jīng)后骨量減少的多中心臨床研究[J].中醫(yī)正骨,2017,29(4):1-7.
相似文獻/References:
[1]潘雄,劉其順,應(yīng)行,等.中藥聯(lián)合4步康復(fù)鍛煉法對骨質(zhì)疏松性椎體壓縮
骨折患者生存質(zhì)量的影響[J].中醫(yī)正骨,2015,27(04):65.
[2]宋永枝,陳雙玲.唑來膦酸靜脈滴注聯(lián)合鮭降鈣素肌肉注射治療
骨質(zhì)疏松性長骨骨折[J].中醫(yī)正骨,2016,28(01):70.
[3]吳鵬,王博,孔令成,等.強骨飲顆粒聯(lián)合阿侖膦酸鈉維D3片口服在原發(fā)性骨質(zhì)疏松性髖部骨折術(shù)后抗骨質(zhì)疏松治療中的應(yīng)用[J].中醫(yī)正骨,2016,28(05):16.
WU Peng,WANG Bo,KONG Lingcheng,et al.Oral application of Qiangguyin Keli(強骨飲顆粒)and alendronate sodium Vitamin D3 tablets in postoperative anti-osteoporosis treatment in patients with primary osteoporotic hip fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(02):16.
[4]陳建德,樊曉琦,夏炳江,等.球囊擴張部位對椎體后凸成形術(shù)治療骨質(zhì)疏松性椎體壓縮骨折療效及安全性的影響[J].中醫(yī)正骨,2017,29(02):11.
CHEN Jiande,FAN Xiaoqi,XIA Bingjiang,et al.Influence of balloon dilation position on curative effect and safety of percutaneous kyphoplasty for treatment of osteoporotic vertebral compression fractures[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(02):11.
[5]史曉林,王健,王博,等.脆性骨折的防治進展[J].中醫(yī)正骨,2017,29(05):20.
[6]陳勍,劉鐘,陳文亮,等.股骨近端防旋髓內(nèi)釘固定聯(lián)合口服仙靈骨葆膠囊治療腎陽虛型骨質(zhì)疏松性股骨轉(zhuǎn)子間骨折[J].中醫(yī)正骨,2017,29(07):69.
[7]曾武,林曙峰,朱俊峰,等.女性骨質(zhì)疏松性橈骨遠(yuǎn)端骨折鎖定鋼板內(nèi)固定術(shù)后腕關(guān)節(jié)功能恢復(fù)的影響因素分析[J].中醫(yī)正骨,2017,29(08):39.
ZENG Wu,LIN Shufeng,ZHU Junfeng,et al.Analysis of factors influencing wrist function recovery after locking plate internal fixation for treatment of osteoporotic distal radius fractures in female[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(02):39.
[8]丁志清,顏峰,喻燦明,等.椎體后凸成形術(shù)后非典型骨水泥植入綜合征死亡1例[J].中醫(yī)正骨,2017,29(11):76.
[9]俞興,王婷,楊濟洲,等.經(jīng)皮椎體成形術(shù)和經(jīng)皮椎體后凸成形術(shù)治療Kmmell病的對比研究[J].中醫(yī)正骨,2018,30(06):23.
YU Xing,WANG Ting,YANG Jizhou,et al.A retrospective trial of percutaneous vertebroplasty versus percutaneous kyphoplasty for treatment of Kmmell's diseases[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(02):23.
[10]彭小東,張曉剛,趙文韜,等.有限元分析在過伸復(fù)位治療骨質(zhì)疏松性椎體壓縮性骨折生物力學(xué)研究中的應(yīng)用進展[J].中醫(yī)正骨,2018,30(07):25.
[11]范星華.骨痿骨折的中醫(yī)病機探討[J].中醫(yī)正骨,2022,34(09):67.